Diagnostic value of the SARC-f questionnaire and muscle strength tests for the detection of sarcopenia in patients with rheumatoid arthritis

Торопцова, Н. В.; Добровольская, О. В.; Efremova, A.; Никитинская, О. А.

doi:10.47360/1995-4484-2020-678-682

Naučno-praktičeskaâ revmatologiâ

2021

DOI: 10.47360/1995-4484-2020-678-682

|View full text |Cite

Diagnostic value of the SARC-f questionnaire and muscle strength tests for the detection of sarcopenia in patients with rheumatoid arthritis

Н. В. Торопцова¹,

О. В. Добровольская²,

A. Efremova³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2024

Publication Types

Select...

Article5

Relationship

Self Cite1

Independent4

Authors

Journals

Cited by 6 publications

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Modulation of oxidative stress as an early symptom of sarcopenia in type 2 diabetes mellitus

Samoilova,

Khoroshunova,

Matveeva

et al. 2024

Rus. J. Prev. Med.

View full text Add to dashboard Cite

Modulation of oxidative stress as an early symptom of sarcopenia in type 2 diabetes mellitus

Samoilova,

Khoroshunova,

Matveeva

et al. 2024

Rus. J. Prev. Med.

View full text Add to dashboard Cite

Sarcopenic phenotype and functional status of skeletal muscles in rheumatoid arthritis patients with biological therapy

Dobrovolskaya,

Demin,

Feklistov

et al. 2023

Klinicist

Self Cite

View full text Add to dashboard Cite

Aim. To evaluate skeletal muscle mass, muscle strength and physical performance in rheumatoid arthritis (RA) women with biological therapy.Materials and methods. The study included 63 women (average age 60.3 ± 8.9 years) with confirmed RA treated with biological therapy and 117 age-matched RA patients who had never previously treated with biological therapy. Clinical and laboratory examination, evaluation of body composition using dual-energy X-ray densitometry and tests to assess muscle strength and physical performance were carried out.Results. The frequency of sarcopenic phenotype among RA patients was 23.3 %: in those who received biological medication – 27.0 %, in the control – 21.4 % (p > 0.05). There were no differences between the groups based on the results of muscle strength assessment tests, however, patients on biological therapy performed significantly better the short physical performance battery (SPPB) and had a higher walking speed (p = 0.016 and p = 0.002, respectively). Univariate linear regression analysis confirmed the relationship of the presence of biological therapy with the functional status of the muscles according to the results of SPPB (b* = 0.24; p = 0.018) and walking speed (b* = 0.28; p = 0.006).Conclusion. The frequency of sarcopenic phenotype among patients with RA was 23.3 % and was comparable in those who received biological therapy and without it. There were no differences in muscle strength depending on the presence of biological therapy, but the functional status of skeletal muscles was significantly better in women who received such treatment.

show abstract

All you need to know about sarcopenia: a short guide for an internal medicine physician in questions and answers

Bikbavova,

Livzan,

Tikhonravova

2023

Bûll. sib. med.

View full text Add to dashboard Cite

Sarcopenia is associated with social, economic, and individual burdens, including loss of independence, poor quality of life, and disability. In a short period of time, ideas about sarcopenia transformed from geriatric syndrome to disease. Initially, sarcopenia was considered in the context of gradual age-related deterioration in the functioning of all physiological systems. Over the years, it became clear that it can develop a second time, as a consequence of various diseases and pathological conditions.To date, there have been no generally accepted diagnostic criteria for sarcopenia. There are several tests and tools available for screening sarcopenia, the choice of which depends on physical capabilities of the patient, capabilities of the medical institution, and the purpose for which it is detected (research or clinical practice).From the point of view of human health, sarcopenia increases the risk of falls and fractures; impairs the ability to perform daily activities; is associated with the progression of major diseases and cognitive impairments; leads to movement disorders; contributes to a decrease in the quality of life, loss of independence or a need for long-term care. The presence of sarcopenia increases both the risk of hospitalization and hospitalization costs.The aim of the literature review is to provide an analysis of up-to-date information on the causes, pathogenesis, screening, diagnosis, treatment, and consequences of sarcopenia, myosteatosis, and sarcopenic obesity. The search for literature containing information on relevant studies was conducted in PubMed and Google Scholar by the following keywords: sarcopenia, dynapenia, myosteatosis, sarcopenic obesity, nutritional status, malnutrition.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Diagnostic value of the SARC-f questionnaire and muscle strength tests for the detection of sarcopenia in patients with rheumatoid arthritis

Cited by 6 publications

References 11 publications

Modulation of oxidative stress as an early symptom of sarcopenia in type 2 diabetes mellitus

Modulation of oxidative stress as an early symptom of sarcopenia in type 2 diabetes mellitus

Sarcopenic phenotype and functional status of skeletal muscles in rheumatoid arthritis patients with biological therapy

All you need to know about sarcopenia: a short guide for an internal medicine physician in questions and answers

Contact Info

Product

Resources

About